JP2004516329A5 - - Google Patents

Download PDF

Info

Publication number
JP2004516329A5
JP2004516329A5 JP2002552942A JP2002552942A JP2004516329A5 JP 2004516329 A5 JP2004516329 A5 JP 2004516329A5 JP 2002552942 A JP2002552942 A JP 2002552942A JP 2002552942 A JP2002552942 A JP 2002552942A JP 2004516329 A5 JP2004516329 A5 JP 2004516329A5
Authority
JP
Japan
Prior art keywords
carbon atoms
substituted
independently
alkyl
nha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002552942A
Other languages
English (en)
Japanese (ja)
Other versions
JP4550361B2 (ja
JP2004516329A (ja
Filing date
Publication date
Priority claimed from DE10064994A external-priority patent/DE10064994A1/de
Application filed filed Critical
Publication of JP2004516329A publication Critical patent/JP2004516329A/ja
Publication of JP2004516329A5 publication Critical patent/JP2004516329A5/ja
Application granted granted Critical
Publication of JP4550361B2 publication Critical patent/JP4550361B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002552942A 2000-12-23 2001-12-03 スルファミドチエノピリミジン Expired - Fee Related JP4550361B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10064994A DE10064994A1 (de) 2000-12-23 2000-12-23 Sulfamidothienopyrimidine
PCT/EP2001/014102 WO2002051848A2 (de) 2000-12-23 2001-12-03 Sulfamidothienopyrimidine zur verwendung als phosphodiesterase v-hemmer

Publications (3)

Publication Number Publication Date
JP2004516329A JP2004516329A (ja) 2004-06-03
JP2004516329A5 true JP2004516329A5 (enExample) 2009-07-23
JP4550361B2 JP4550361B2 (ja) 2010-09-22

Family

ID=7668967

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002552942A Expired - Fee Related JP4550361B2 (ja) 2000-12-23 2001-12-03 スルファミドチエノピリミジン

Country Status (19)

Country Link
US (1) US7019013B2 (enExample)
EP (1) EP1353927B1 (enExample)
JP (1) JP4550361B2 (enExample)
KR (1) KR20030062438A (enExample)
CN (1) CN1483035A (enExample)
AR (1) AR035524A1 (enExample)
AT (1) ATE302781T1 (enExample)
BR (1) BR0115996A (enExample)
CA (1) CA2432582C (enExample)
CZ (1) CZ20031815A3 (enExample)
DE (2) DE10064994A1 (enExample)
ES (1) ES2247007T3 (enExample)
HU (1) HUP0302515A3 (enExample)
MX (1) MXPA03005714A (enExample)
PL (1) PL361733A1 (enExample)
RU (1) RU2003122189A (enExample)
SK (1) SK8432003A3 (enExample)
WO (1) WO2002051848A2 (enExample)
ZA (1) ZA200305659B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849638B2 (en) * 2001-04-30 2005-02-01 Bayer Pharmaceuticals Corporation 4-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of pde7b-mediated diseases and conditions
CN101163706A (zh) * 2005-04-21 2008-04-16 贝林格尔·英格海姆国际有限公司 用于治疗炎性疾病的二氢噻吩并嘧啶
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
US8080549B2 (en) * 2007-01-12 2011-12-20 Concert Pharmaceuticals, Inc. Endothelin receptor antagonists
WO2008088727A2 (en) 2007-01-12 2008-07-24 Concert Pharmaceuticals, Inc. Endothelin receptor antagonists
JP2010516734A (ja) 2007-01-24 2010-05-20 グラクソ グループ リミテッド 3,5−ジアミノ−6−(2,3−ジクロロフェニル)−1,2,4−トリアジンまたはr(−)−2,4−ジアミノ−5−(2,3−ジクロロフェニル)−6−フルオロメチルピリミジンを含む医薬組成物
ES2524910T3 (es) 2007-10-19 2014-12-15 Boehringer Ingelheim International Gmbh Piperidino-dihidrotienopirimidinas sustituidas
JP5341899B2 (ja) 2007-10-19 2013-11-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ヘテロ環置換ピペラジノ−ジヒドロチエノピリミジン
ATE537175T1 (de) 2007-10-19 2011-12-15 Boehringer Ingelheim Int Neue piperazino-dihydrothienopyrimidin-derivate
JP6042331B2 (ja) 2010-07-23 2016-12-14 プレジデント アンド フェローズ オブ ハーバード カレッジ プロテアソーム活性を向上させる三環系化合物
US20130059866A1 (en) 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
US9802954B2 (en) 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
EP2806875B1 (en) * 2012-01-25 2017-07-19 Proteostasis Therapeutics, Inc. Proteasome activity modulating compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19644228A1 (de) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
DE19752952A1 (de) * 1997-11-28 1999-06-02 Merck Patent Gmbh Thienopyrimidine
DE19819023A1 (de) * 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine
WO2000059912A1 (en) 1999-03-30 2000-10-12 Nippon Soda Co., Ltd. Thienopyrimidine compounds and salts thereof and process for the preparation of the same

Similar Documents

Publication Publication Date Title
JP2004516329A5 (enExample)
JP2002332234A5 (enExample)
JP2006526031A5 (enExample)
JP2007510619A5 (enExample)
JP2002535332A5 (enExample)
JP2003176417A5 (enExample)
JP2002541233A5 (enExample)
JP2007534702A5 (enExample)
JP2001526218A5 (enExample)
JP2003528918A5 (enExample)
JP2002540208A5 (enExample)
JP2010520214A5 (enExample)
JP2002527474A5 (ja) 躁病および双極性障害の治療のための医薬
JP2002513026A5 (enExample)
JP2007506721A5 (enExample)
JP2002506864A5 (enExample)
JP2000159790A5 (enExample)
JP2012518649A5 (enExample)
JP2013503881A5 (enExample)
JP2005510457A5 (enExample)
JP2012511558A5 (enExample)
JP2003529598A5 (enExample)
JP2004519450A5 (enExample)
JP2010045366A5 (enExample)
JP2006510659A5 (enExample)